Target intelligence / Profile preview

Folate analogues

Molecular classification
Other (small molecule, antimetabolite, chemical probe; not a receptor, enzyme, transporter, etc.)
01

Overview

Folate analogues are a broad class of molecules designed to mimic or antagonize the biological actions of folic acid (vitamin B9), a key cofactor for nucleotide and methionine synthesis. These molecules include several antimetabolite chemotherapy agents (such as methotrexate, pemetrexed, and raltitrexed), as well as supplements and rescue agents like leucovorin. Many antifolates act by competitively inhibiting folate-dependent enzymes such as dihydrofolate reductase or thymidylate synthase, thereby disrupting DNA replication and cellular proliferation. They play an essential role in cancer treatment, immune modulation, and anti-infective therapy. Folate analogues are not a target themselves, but a class of therapeutics and probes that exert their action on key molecular targets involved in folate metabolism, such as the folate receptor, DHFR, and other folate transporters and enzymes.

Other names
folic acid analoguesantifolatesfolate antagonistsfolic acid derivatives
02

Mechanism of action

Competitive inhibition of folate-dependent enzymes, including dihydrofolate reductase (DHFR), thymidylate synthase, and others; Disruption of nucleotide synthesis (purines, thymidylate); Rescue or modulation of folate pathways (with reduced or alternative folate forms)

03

Biological functions

Modulation of folate metabolismInhibition of nucleotide synthesisAnti-tumor activityAnti-inflammatory and antimicrobial effects
04

Disease associations

Cancer (various solid tumors and hematologic malignancies)Autoimmune disease (e.g., rheumatoid arthritis, psoriasis)Infectious diseases (antimicrobial/antiprotozoal/antifungal activity)
05

Safety considerations

MyelosuppressionMucositis/gastrointestinal toxicityRenal and hepatic toxicityImmunosuppression/infection riskPotential for resistance in cancer
06

Interacting drugs

Methotrexate

7 more in the full profile.

07

Biomarkers

Expression of folate receptor alpha (FOLR1) in tumors for targeted therapies and diagnosticsFolate receptor beta in activated macrophages/immune disordersSerum folate metabolites in deficiency disorders

Beyond the preview

Go deeper on Folate analogues.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Folate analogues.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call